Virus Infections and Host Metabolism-Can We Manage the Interactions?

被引:91
作者
Sumbria, Deepak [1 ]
Berber, Engin [1 ,2 ]
Mathayan, Manikannan [3 ]
Rouse, Barry T. [1 ]
机构
[1] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA
[2] Erciyes Univ, Fac Vet Med, Dept Virol, Kayseri, Turkey
[3] Sathyabama Inst Sci & Technol, Ctr Drug Discovery & Dev, Chennai, Tamil Nadu, India
关键词
virus; metabolism; interferon; diabetes; obesity; short chain fatty acids; metabolic blockers; REPLICATION; CHILDREN; ACTIVATION; MORBIDITY;
D O I
10.3389/fimmu.2020.594963
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
When viruses infect cells, they almost invariably cause metabolic changes in the infected cell as well as in several host cell types that react to the infection. Such metabolic changes provide potential targets for therapeutic approaches that could reduce the impact of infection. Several examples are discussed in this review, which include effects on energy metabolism, glutaminolysis and fatty acid metabolism. The response of the immune system also involves metabolic changes and manipulating these may change the outcome of infection. This could include changing the status of herpesviruses infections from productive to latency. The consequences of viral infections which include coronavirus disease 2019 (COVID-19), may also differ in patients with metabolic problems, such as diabetes mellitus (DM), obesity, and endocrine diseases. Nutrition status may also affect the pattern of events following viral infection and examples that impact on the pattern of human and experimental animal viral diseases and the mechanisms involved are discussed. Finally, we discuss the so far few published reports that have manipulated metabolic events in-vivo to change the outcome of virus infection. The topic is expected to expand in relevance as an approach used alone or in combination with other therapies to shape the nature of virus induced diseases.
引用
收藏
页数:14
相关论文
共 171 条
[1]   Diabetes and COVID-19: A systematic review on the current evidences [J].
Abdi, Alireza ;
Jalilian, Milad ;
Sarbarzeh, Pegah Ahmadi ;
Vlaisavljevic, Zeljko .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 166
[2]   Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections [J].
Adams, O ;
Besken, K ;
Oberdörfer, C ;
MacKenzie, CR ;
Takikawa, O ;
Däubener, W .
JOURNAL OF VIROLOGY, 2004, 78 (05) :2632-2636
[3]   Inhibition of human herpes simplex virus type 2 by interferon γ and tumor necrosis factor α is mediated by indoleamine 2,3-dioxygenase [J].
Adams, O ;
Besken, K ;
Oberdörfer, C ;
MacKenzie, CR ;
Rüssing, D ;
Däubener, W .
MICROBES AND INFECTION, 2004, 6 (09) :806-812
[4]   Influence of thyroid hormone disruption on the incidence of shingles [J].
Ajavon, A. ;
Killian, D. ;
Odom, R. ;
Figliozzi, R. W. ;
Chen, F. ;
Balish, M. ;
Parmar, J. ;
Freeman, R. ;
Snitzer, J. ;
Hsia, S. V. .
EPIDEMIOLOGY AND INFECTION, 2015, 143 (16) :3557-3571
[5]  
Al-Benna Sammy, 2020, Obes Med, V19, P100283, DOI 10.1016/j.obmed.2020.100283
[6]   Viral mechanisms of immune evasion [J].
Alcami, A ;
Koszinowski, UH .
TRENDS IN MICROBIOLOGY, 2000, 8 (09) :410-418
[7]   Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection [J].
Allard, Robert ;
Leclerc, Pascale ;
Tremblay, Claude ;
Tannenbaum, Terry-Nan .
DIABETES CARE, 2010, 33 (07) :1491-1493
[8]  
ALQAHTANI F, 2018, SCI REP-UK, V147, pE35, DOI DOI 10.1017/S0950268818002923
[9]  
[Anonymous], 2020, N Engl J Med, V382, P1708, DOI DOI 10.1056/NEJMOA2002032
[10]  
ANTUNES K, 2019, PROSTAG LEUKOTR ESS, V10, P3273, DOI DOI 10.1038/S41467-019-11152-6